Moyamoya disease with Sjogren disease and autoimmune thyroiditis presenting with left intracranial hemorrhage after messenger RNA-1273 vaccination: A case report

RATIONALE: The new vaccines are emergently authorized and currently approved for use to protect against the coronavirus disease 2019 (COVID-19) pandemic and serious adverse events are uncommon. Moyamoya disease (MMD) with autoimmune disease is a rare entity and usually presents with intracranial hem...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Yi-Hsin, Huang, Hsuan, Hwang, Wen-Zern
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
5300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830843/
https://www.ncbi.nlm.nih.gov/pubmed/35147099
http://dx.doi.org/10.1097/MD.0000000000028756

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830843/
https://www.ncbi.nlm.nih.gov/pubmed/35147099
http://dx.doi.org/10.1097/MD.0000000000028756

Ejemplares similares